chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After my second Moderna vaccine shot I got tennitus; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (After my second Moderna vaccine shot I got tennitus) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (After my second Moderna vaccine shot I got tennitus). At the time of the report, TINNITUS (After my second Moderna vaccine shot I got tennitus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.
she couldn't put her arm down all day; it was swollen and painful underneath the arm; it was swollen and painful underneath the arm; cramp in her upper right arm; First dose: given on 16Sep2021/Second dose: Given on 23Nov2021; at least three very large swollen lymph nodes under the right arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 23Nov2021 (Lot number: FH8028) at the age of 52 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing), notes: Additional Information for Concomitant Products Bystolic: She has been on it years. Concomitant medication(s) included: BYSTOLIC taken for hypertension (ongoing). Vaccination history included: Bnt162b2 (Dose Number:01, Lot number: FD8448), administration date: 16Sep2021, when the patient was 52 years old, for Covid-19 Immunization, reaction(s): "she thinks it did something to her heart rate/Her heart rate is usually 80 to 100 and it was around 50", "she still felt really tired". The following information was reported: MUSCLE SPASMS (non-serious) with onset 24Nov2021, outcome "not recovered", described as "cramp in her upper right arm"; LIMB DISCOMFORT (non-serious) with onset 25Nov2021, outcome "unknown", described as "she couldn't put her arm down all day"; PERIPHERAL SWELLING (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 25Nov2021, outcome "unknown" and all described as "it was swollen and painful underneath the arm"; LYMPHADENOPATHY (non-serious) with onset 2021, outcome "unknown", described as "at least three very large swollen lymph nodes under the right arm"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 23Nov2021, outcome "unknown", described as "First dose: given on 16Sep2021/Second dose: Given on 23Nov2021". The events "cramp in her upper right arm", "she couldn't put her arm down all day", "it was swollen and painful underneath the arm", "it was swollen and painful underneath the arm" and "at least three very large swollen lymph nodes under the right arm" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of muscle spasms.  Additional information: After the first shot she thinks it did something to her heart rate. She can't prove it. It was a few weeks after the first shot that she noticed she still felt really tired. She checks her blood pressure on a regular basis because she is on blood pressure medicine. Her heart rate is usually 80 to 100 and it was around 50. She went to the emergency room and they did heart test. Nothing came back. Everything seems ok now. They will do a stress test in the future on 23Dec2021.  No follow-up attempts are possible. No further information is expected.
Oral lesions of cheeks, tongue, gums and throat. Blistering of skin after second shot.
The injection site is all red; The injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (The injection site is all red) and VACCINATION SITE SWELLING (The injection site is swollen) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (The injection site is all red) and VACCINATION SITE SWELLING (The injection site is swollen). At the time of the report, VACCINATION SITE ERYTHEMA (The injection site is all red) and VACCINATION SITE SWELLING (The injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Friday PM painful lt shoulder;Saturday PM pain extending to lt side of neck into lt arm-Saturday PM very painful lt mid collar bone-3 red lines noted from inj site up neck over inner shoulder;dx lymphangitis;
Information has been received from a physician concerning an approximately 10 week old female who was vaccinated with rotavirus vaccine (human-bovine) (Lot # 656194/0024U). Concomitant vaccinations included diphtheria toxoid (+) pertussia acellular vaccine (unspecified) (+) tetanus toxoid, hepatitis B virus vaccine (unknown manufacturer) and poliovirus vaccine. Subsequently, the patient experienced diarrhea for a couple of days after receiving rotavirus vaccine (human-bovine). Subsequently, the patient is fine and the diarrhea cleared on its own. The patient sought unspecified medical attention. Additional information has been requested.
after first dose, urticarial/welt rash  after second doe, more diffuse urticarial rash with swelling of face, neck, hands and feet and scrotum
Achy arm; Really really tired; Queasy stomach; Headache; Achy muscles; Little bitty fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Queasy stomach), PAIN IN EXTREMITY (Achy arm), HEADACHE (Headache), MYALGIA (Achy muscles) and PYREXIA (Little bitty fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 007M214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Queasy stomach), HEADACHE (Headache), MYALGIA (Achy muscles) and PYREXIA (Little bitty fever). On an unknown date, the patient experienced PAIN IN EXTREMITY (Achy arm) and FATIGUE (Really really tired). At the time of the report, ABDOMINAL DISCOMFORT (Queasy stomach), PAIN IN EXTREMITY (Achy arm), HEADACHE (Headache), MYALGIA (Achy muscles), PYREXIA (Little bitty fever) and FATIGUE (Really really tired) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Approximately 10 days, post vax, he experienced generalized muscle aches followed by fever to 102. He was seen by physician. No treatment was given. The most recent information, received on 10/21/99, reports the condition of the pt is ongoing.
nausea; chills; fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), CHILLS (chills), PYREXIA (fever) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure and Cholesterol. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and CHOLESTEROL for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea), CHILLS (chills), PYREXIA (fever) and FATIGUE (fatigue). At the time of the report, NAUSEA (nausea), CHILLS (chills), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Client experienced, itchy throat, and slight headache five minutes after injection was given at vaccine site.  Client alerted staff,  the EMT checked vitals, symptoms cleared before EMT spoke with patient.  Client was clear to leave site.  No medications administered.
Right testicular started hurting/ feels like they were being pinched internally on the right testicles; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TESTICULAR PAIN (Right testicular started hurting/ feels like they were being pinched internally on the right testicles), PYREXIA (Fever) and CHILLS (Chills) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041821A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Jun-2021, the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 06-Jun-2021, the patient experienced TESTICULAR PAIN (Right testicular started hurting/ feels like they were being pinched internally on the right testicles). At the time of the report, TESTICULAR PAIN (Right testicular started hurting/ feels like they were being pinched internally on the right testicles), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided. Treatment information was not provided.   This case was linked to MOD-2021-212218 (Patient Link).
?Covid arm??after about 8 days, red, swollen, warm area with itchy bumps
Erythema, pain, swelling  and weeping liquid at injection site. Pt sort treatment and was given antibiotic.
Syncope; Unconscious for approximately 1 minute; This case was reported by a other health professional via sales rep and described the occurrence of syncope in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number C5JL7, expiry date 28th November 2021) for prophylaxis.   On an unknown date, the patient received Boostrix (intramuscular). On an unknown date, unknown after receiving Boostrix, the patient experienced syncope (serious criteria GSK medically significant) and unconscious (serious criteria GSK medically significant). On an unknown date, the outcome of the syncope and unconscious were recovered/resolved.   It was unknown if the reporter considered the syncope and unconscious to be related to Boostrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Boostrix and 2 other non-GlaxoSmithKline vaccines, the patient had a syncope event in which she was unconscious for approximately 1 minute.  The patient recovered and went home without requiring any treatment.  The reporter was consented to follow up.
Symptoms begun at 7:30 pm (9 hours post-vaccine) with feeling feverish and generally unwell. Initial temperature was 99.6 (note: my normal temperature averages 96.8-97.8).  Temperature continued to escalate quickly and was accompanied by chills, body aches, and nausea initially. The highest temperature I recorded was 102.6 with a HR of 105-110. Tylenol PM was taken and fever was only reduced to 101.8. Vomiting occurred over night at 2:00 am on 2/3. Fever, chills, body aches, severe sweats, and fatigue continued into the next morning and I had another episode of vomiting. Temperature finally dropped to 99-100 around 2:00 pm on 2/3 and remained until at 6:00 pm when it was 98. Headache occurred that evening lasting through the morning of 2/4. Symptoms have mostly resolved.
pain in left deltoid can't raise arm, turn steering wheal sleep on that side. Pinpoint pain posterolat aspect of deltoid. Limited range of motion, Rx for Naproxen Sodium 500mg one twice a day with food
Patient got 2 doses of Pfizer (3 week interval) when patients was only 15 years of age.
FLU SYMPTOMS/FEVER/CHILLS/HEADACHE/ACHES AND PAINS; COLD SYMPTOMS; This spontaneous report received from a consumer concerned a 51 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced flu symptoms/fever/chills/headache/aches and pains. On 07-APR-2021, the subject experienced cold symptoms. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cold symptoms, and had not recovered from flu symptoms/fever/chills/headache/aches and pains. This report was non-serious.
Patient received a dose of Pfizer vaccine where the dose exceeded beyond use dating (BUD) as determined by manufacturer by 5 days.  As advised by Pfizer, they recommended that he receive an additional dose of vaccine as soon as possible to ensure appropriate protection.  Patient was given this information and received dose today.
About an hour after receiving the Flu vaccination I began having sharp pain in my upper back next to my left shoulder blade and within another half hour it also traveled to my lower left back. I received the shot in my left shoulder.
Pt noticed pain and visible swelling in L axilla spreading down the side of her breast & ribs to 7th intercostal space and up towards her clavicle.  Denies any redness to area or area feeling hot to touch.  States also on L side of chest down to 4th intercostal space directly above breast tissue and just below clavicle feels hard like an enlarged lymph node as does area along side of breast.  Taking OTC Advil and applying ice packs to area for pain and swelling management.  Pt is scheduled for appointment tomorrow for in person evaluation of site.
Left thigh induration measuring 10.5cm x 19cm, nontender, warm erythroderma around left thigh punctum, no vesicles, no pustules, no LA streaking, no inguinal LA, no other rashes. Improved w/ cool compresses.
Information has been received from a registered  nurse concerning a 9 year old male with no reported medical history who on 15-DEC-1999 was vaccinated once with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On 26-MAY-2007 the patient developed chickenpox rash. When the nurse saw him on 29-MAY-2007, the mildly itchy rash was vesicular and crusting on his upper thigh and trunk. No laboratory or diagnostic tests were performed. Unspecified medical attention was sought. No product quality complaint was involved. The patient's sibling experienced lesions following his second dose of vaccination with varicella virus vaccine live (Oka/Merck) (WAES# 0708USA00107). Additional information has been requested.
Patient received initial HPV vaccine 8 days ago.  Reported redness, warmth, swelling, pain at injection site 1 day ago. No other symptoms.    Today at visit there is some mild induration  but no erythema or swelling noted.  No warmth.   Some tenderness.   Patient has been treating pain with ibuprofen
This spontaneous report has been received from an 80 year old female patient concerning herself. The patient did not have pertinent medical history, drug reactions or allergies, concurrent conditions or concomitant medications. On an unspecified date in April 2017, the patient was vaccinated with ZOSTAVAX (strength, dose, route, anatomical location, lot number and expiration date were not provided) for prophylaxis. On approximately 23-JAN-2018 (reported as "last week"), the patient developed mild case of shingles on both hands. The outcome of herpes zoster was unknown. The patient sought medical attention and received unspecified treatment. No laboratory studies were performed. The causality assessment between therapy with ZOSTAVAX and the event was not reported.
Complaining of soreness, redness, and warmth at injection site. On 7/11/12 temperature 100 degrees and aching all over.
This case was reported by a consumer and described the occurrence of fever in a 6 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix). A physician or other health care professional has not verified this report. On 6JULY2004, the patient received a dose of Pediarix. On 6JULY2004 the patient also received administrations of 7 valent conjugate Pneumococcal vaccine and Hib type b conjugate vaccine. At an unspecified time following the administration of the immunizations, on 6JULY2004, the patient experienced a fever of 105 degrees F, crying and body shakes.  The patient was treated with ibuprofen(Motrin). The events resolved in 24 hours. Anonymous report. Follow-up not possible.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 79-year-old male patient who received SHINGRIX for prophylaxis. In July 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 5th October 2018, less than a year after receiving SHINGRIX, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were recovered/resolved. It was unknown if the reporter considered the shingles and pain to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient for himself. The patient SHINGRIX injection the end of July 2018. After vaccination, the patient experienced outbreak of shingles. It was not as severe as it could have been. The pain was resolved about one week before the date of reporting. Consent to follow up was given. The patient has no relation with this physician - just shares same last name.
Arm was hurting after first dose; Was getting itching in his hands; Finger tips had swelling; This is a spontaneous report from a Pfizer-sponsored program . This is a spontaneous report from a non-contactable male consumer reported for himself that: A male patient of an unspecified age received first dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation. Medical history included Herniated disc and Back pain from an unknown date and unknown if ongoing. Concomitant medication(s) included hydrocodone (HYDROCODONE) taken for Herniated disc and Back pain, start and stop date were not reported. On an unspecified date, the patient experienced his arm was hurting, added that about a week ago, he was getting to itch in his hands; his fingertips would swell up, not on the nail side. It started on one hand and the other day was on the other hand. Yesterday swelling was on right hand and today it was on the left hand. The itching had gone away. The patient was taking 5mg for about 2 years for a herniated disc and back pain. He wanted to know if it was safe to take the second shot with the medication. Caller clarified pain medication as Hydrocodone 5mg, one every 8 hours. The outcome of the events Arm was hurting after first dose and Fingertips had swelling was unknown and for was getting to itch in his hands it was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt. states that after receiving the 2nd dose of Moderna 10/01/2021, started experiencing symptoms 10/02/2021 Stomach pains, fatigued, passed out 3hrs, and feverish. No noted Primary Visit.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 44 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Htn" (unspecified if ongoing), notes: other medical history: Htn; "Known allergy: Latex" (unspecified if ongoing), notes: Known allergy: Latex. Concomitant medication(s) included: LISINOPRIL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received the anti-viral treatment details, brand: Paxlovid, treatment started date on 10Sep2022, treatment end on 15Sep2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the Reported events COVID-19, DRUG INEFFECTIVE and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Cough productive, diffuse body aches, coryza, itchy eyes, severe malaise.
Patient reported symptoms started on 2/11/21 with low grade fever, "fuzzy head", sore arm and body aches. Patient will take tylenol or ibuprofen as needed.
Patient received both vaccines in our office on 11/22/21 and around 6pm that evening she started with fever and urticaria. Her fever got up to 102 and her parents treated it with Tylenol and Motrin rotating.
vaccine was used beyond the 12 hours expiration date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was used beyond the 12 hours expiration date) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was used beyond the 12 hours expiration date). On 05-May-2021, EXPIRED PRODUCT ADMINISTERED (vaccine was used beyond the 12 hours expiration date) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    This case was linked to US-MODERNATX, INC.-MOD-2021-106540 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: follow-up was received on 05-MAY-2021 contain no new information On 10-May-2021: follow-up was received on 10-may-2021 and updated date of first Moderna Covid-19 vaccine dose was recorded; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-106540: